In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin) an optically active ofloxacinFU, K. P; LAFREDO, S. C; FOLENO, B et al.Antimicrobial agents and chemotherapy. 1992, Vol 36, Num 4, pp 860-866, issn 0066-4804Article

Experimental efficacy and pharmacokinetic properties of cefpiramide, a new cephalosporinFU, K. P; VINCE, T; MCCLOUD, S et al.Drugs under experimental and clinical research. 1985, Vol 11, Num 11, pp 787-791, issn 0378-6501Article

Clearance of a novel recombinant tissue plasminogen activator in rabbitsFU, K. P; LEE, S; HETZEL, N et al.Thrombosis research. 1988, Vol 50, Num 5, pp 679-685, issn 0049-3848Article

Therapeutic efficacy and pharmacokinetic properties of Ciprofloxacin in intra-abdominal abcesses caused by Bacteroides fragilis and Escherichia coliFU, K. P; VINCE, T; BLOOM, R et al.Drugs under experimental and clinical research. 1987, Vol 13, Num 8, pp 493-496, issn 0378-6501Article

In vitro activity of l-ofloxacin against norfloxacin-resistant coagulase-negative staphylococciFOLENO, B; FU, K. P.Diagnostic microbiology and infectious disease. 1992, Vol 15, Num 6, pp 557-559, issn 0732-8893Article

In-vivo evaluation of ofloxacin in Salmonella typhimurium infection in miceFU, K. P; HILLIARD, J; ISAACSON, D et al.Journal of antimicrobial chemotherapy (Print). 1990, Vol 25, Num 2, pp 263-268, issn 0305-7453Article

Structure-function analysis with tissue-type plasminogen activator: effect of deletion of NH₂-terminal domains on its biochemical and biological propertiesKALYAN, N. K; SHAW GUANG LEE; WILHELM, J et al.The Journal of biological chemistry (Print). 1988, Vol 263, Num 8, pp 3971-3978, issn 0021-9258Article

Discrepancy between the antibacterial activities and the inhibitory effects on Micrococcus luteus DNA gyrase of 13 quinolonesFU, K. P; GRACE, M. E; MCCLOUD, S. J et al.Chemotherapy (Basel). 1986, Vol 32, Num 6, pp 494-498, issn 0009-3157Article

Experimental efficacy of apalcillin and cefpiramide compared with that of six other antipseudomonal agents in Pseudomonas aeruginosa burn infectionsFU, K. P; VINCE, T; HUNG, P. P et al.Drugs under experimental and clinical research. 1986, Vol 12, Num 4, pp 303-306, issn 0378-6501Article

In vitro activity of levofloxacin, ofloxacin and other quinolones against coagulase-negative staphylococciFOLENO, B. D; LAFREDO, S. C; FU, K. P et al.Chemotherapy (Basel). 1993, Vol 39, Num 2, pp 120-123, issn 0009-3157Article

In vitro and in vivo antibacterial activities of FK037, a novel parenteral broad-spectrum cephalosporinFU, K. P; FOLENO, B. D; LAFREDO, S. C et al.Antimicrobial agents and chemotherapy. 1993, Vol 37, Num 2, pp 301-307, issn 0066-4804Article

Induction of resistance of Streptococcus pneumoniae to quinolones in vitroLAFREDO, S. C; FOLENO, B. D; FU, K. P et al.Chemotherapy (Basel). 1993, Vol 39, Num 1, pp 36-39, issn 0009-3157Article

The postantibiotic suppressive effect of L-ofloxacin, an optically active isomer of ofloxacinFU, K. P; FOLENO, B; ROSENTHALE, M. E et al.Diagnostic microbiology and infectious disease. 1992, Vol 15, Num 4, pp 375-378, issn 0732-8893Article

Therapeutic efficacy of cefpiramide and cefoperazone alone and in combination with gentamicin against pseudomonal infections in neutropenic miceFU, K. P; HETZEL, N; HUNG, P. P et al.Chemotherapy (Basel). 1986, Vol 32, Num 2, pp 166-172, issn 0009-3157Article

Inhibitory activity of cefpiramide on β-lactamaseFU, K. P; MCCLOUD, S; GREGORY, F. J et al.Chemotherapy (Basel). 1985, Vol 31, Num 3, pp 200-203, issn 0009-3157Article